Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keith E. Szulwach is active.

Publication


Featured researches published by Keith E. Szulwach.


Nature Biotechnology | 2011

Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine

Chun-Xiao Song; Keith E. Szulwach; Ye Fu; Qing Dai; Chengqi Yi; Xuekun Li; Yujing Li; Chih-Hsin Chen; Wen Zhang; Xing Jian; Jing Wang; Li Zhang; Timothy J. Looney; Baichen Zhang; Lucy A. Godley; Leslie M. Hicks; Bruce T. Lahn; Peng Jin; Chuan He

In contrast to 5-methylcytosine (5-mC), which has been studied extensively, little is known about 5-hydroxymethylcytosine (5-hmC), a recently identified epigenetic modification present in substantial amounts in certain mammalian cell types. Here we present a method for determining the genome-wide distribution of 5-hmC. We use the T4 bacteriophage β-glucosyltransferase to transfer an engineered glucose moiety containing an azide group onto the hydroxyl group of 5-hmC. The azide group can be chemically modified with biotin for detection, affinity enrichment and sequencing of 5-hmC–containing DNA fragments in mammalian genomes. Using this method, we demonstrate that 5-hmC is present in human cell lines beyond those previously recognized. We also find a gene expression level–dependent enrichment of intragenic 5-hmC in mouse cerebellum and an age-dependent acquisition of this modification in specific gene bodies linked to neurodegenerative disorders.


Cell | 2012

Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome

Miao Yu; Gary C. Hon; Keith E. Szulwach; Chun-Xiao Song; Liang Zhang; Audrey Kim; Xuekun Li; Qing Dai; Yin Shen; Beomseok Park; Jung Hyun Min; Peng Jin; Bing Ren; Chuan He

The study of 5-hydroxylmethylcytosines (5hmC) has been hampered by the lack of a method to map it at single-base resolution on a genome-wide scale. Affinity purification-based methods cannot precisely locate 5hmC nor accurately determine its relative abundance at each modified site. We here present a genome-wide approach, Tet-assisted bisulfite sequencing (TAB-Seq), that when combined with traditional bisulfite sequencing can be used for mapping 5hmC at base resolution and quantifying the relative abundance of 5hmC as well as 5mC. Application of this method to embryonic stem cells not only confirms widespread distribution of 5hmC in the mammalian genome but also reveals sequence bias and strand asymmetry at 5hmC sites. We observe high levels of 5hmC and reciprocally low levels of 5mC near but not on transcription factor-binding sites. Additionally, the relative abundance of 5hmC varies significantly among distinct functional sequence elements, suggesting different mechanisms for 5hmC deposition and maintenance.


Nature Neuroscience | 2011

5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging

Keith E. Szulwach; Xuekun Li; Yujing Li; Chun-Xiao Song; Hao Wu; Qing Dai; Hasan Irier; Anup K. Upadhyay; Marla Gearing; Allan I. Levey; Aparna Vasanthakumar; Lucy A. Godley; Qiang Chang; Xiaodong Cheng; Chuan He; Peng Jin

DNA methylation dynamics influence brain function and are altered in neurological disorders. 5-hydroxymethylcytosine (5-hmC), a DNA base that is derived from 5-methylcytosine, accounts for ∼40% of modified cytosine in the brain and has been implicated in DNA methylation–related plasticity. We mapped 5-hmC genome-wide in mouse hippocampus and cerebellum at three different ages, which allowed us to assess its stability and dynamic regulation during postnatal neurodevelopment through adulthood. We found developmentally programmed acquisition of 5-hmC in neuronal cells. Epigenomic localization of 5-hmC–regulated regions revealed stable and dynamically modified loci during neurodevelopment and aging. By profiling 5-hmC in human cerebellum, we found conserved genomic features of 5-hmC. Finally, we found that 5-hmC levels were inversely correlated with methyl-CpG–binding protein 2 dosage, a protein encoded by a gene in which mutations cause Rett syndrome. These data suggest that 5-hmC–mediated epigenetic modification is critical in neurodevelopment and diseases.


Journal of Cell Biology | 2010

Cross talk between microRNA and epigenetic regulation in adult neurogenesis

Keith E. Szulwach; Xuekun Li; Richard D. Smrt; Yujing Li; Yuping Luo; Li Lin; Nicholas J. Santistevan; Wendi Li; Xinyu Zhao; Peng Jin

The microRNA miR-137 represses expression of Ezh2, a histone methyltransferase, which in turn alters the epigenetic architecture of chromatin that is important for regulation of miR-137 levels.


Cell | 2013

Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming

Chun-Xiao Song; Keith E. Szulwach; Qing Dai; Ye Fu; Shi-Qing Mao; Li Lin; Craig R Street; Yujing Li; Mickael Poidevin; Hao Wu; Juan Gao; Peng Liu; Lin Li; Guoliang Xu; Peng Jin; Chuan He

TET proteins oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC). 5fC and 5caC are excised by mammalian DNA glycosylase TDG, implicating 5mC oxidation in DNA demethylation. Here, we show that the genomic locations of 5fC can be determined by coupling chemical reduction with biotin tagging. Genome-wide mapping of 5fC in mouse embryonic stem cells (mESCs) reveals that 5fC preferentially occurs at poised enhancers among other gene regulatory elements. Application to Tdg null mESCs further suggests that 5fC production coordinates with p300 in remodeling epigenetic states of enhancers. This process, which is not influenced by 5hmC, appears to be associated with further oxidation of 5hmC and commitment to demethylation through 5fC. Finally, we resolved 5fC at base resolution by hydroxylamine-based protection from bisulfite-mediated deamination, thereby confirming sites of 5fC accumulation. Our results reveal roles of active 5mC/5hmC oxidation and TDG-mediated demethylation in epigenetic tuning at regulatory elements.


Stem Cells | 2010

MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase Mind Bomb-1

Richard D. Smrt; Keith E. Szulwach; Rebecca L. Pfeiffer; Xuekun Li; Weixiang Guo; Manavendra Pathania; Zhao-Qian Teng; Yuping Luo; Junmin Peng; Angélique Bordey; Peng Jin; Xinyu Zhao

The maturation of young neurons is regulated by complex mechanisms and dysregulation of this process is frequently found in neurodevepmental disorders. MicroRNAs have been implicated in several steps of neuronal maturation including dendritic and axonal growth, spine development, and synaptogenesis. We demonstrate that one brain‐enriched microRNA, miR‐137, has a significant role in regulating neuronal maturation. Overexpression of miR‐137 inhibits dendritic morphogenesis, phenotypic maturation, and spine development both in brain and cultured primary neurons. On the other hand, a reduction in miR‐137 had opposite effects. We further show that miR‐137 targets the Mind bomb one (Mib1) protein through the conserved target site located in the 3′ untranslated region of Mib1 messenger RNA. Mib1 is an ubiquitin ligase known to be important for neurodevelopment. We show that exogenously expressed Mib1 could partially rescue the phenotypes associated with miR‐137 overexpression. These results demonstrate a novel miRNA‐mediated mechanism involving miR‐137 and Mib1 that function to regulate neuronal maturation and dendritic morphogenesis during development. STEM Cells 2010;28:1060–1070


PLOS Genetics | 2011

Integrating 5-Hydroxymethylcytosine into the Epigenomic Landscape of Human Embryonic Stem Cells

Keith E. Szulwach; Xuekun Li; Yujing Li; Chun-Xiao Song; Ji Woong Han; Sangsung Kim; Sandeep Namburi; Karen E. Hermetz; Julie J. Kim; M. Katharine Rudd; Young-sup Yoon; Bing Ren; Chuan-Chuan He; Peng-Peng Jin

Covalent modification of DNA distinguishes cellular identities and is crucial for regulating the pluripotency and differentiation of embryonic stem (ES) cells. The recent demonstration that 5-methylcytosine (5-mC) may be further modified to 5-hydroxymethylcytosine (5-hmC) in ES cells has revealed a novel regulatory paradigm to modulate the epigenetic landscape of pluripotency. To understand the role of 5-hmC in the epigenomic landscape of pluripotent cells, here we profile the genome-wide 5-hmC distribution and correlate it with the genomic profiles of 11 diverse histone modifications and six transcription factors in human ES cells. By integrating genomic 5-hmC signals with maps of histone enrichment, we link particular pluripotency-associated chromatin contexts with 5-hmC. Intriguingly, through additional correlations with defined chromatin signatures at promoter and enhancer subtypes, we show distinct enrichment of 5-hmC at enhancers marked with H3K4me1 and H3K27ac. These results suggest potential role(s) for 5-hmC in the regulation of specific promoters and enhancers. In addition, our results provide a detailed epigenomic map of 5-hmC from which to pursue future functional studies on the diverse regulatory roles associated with 5-hmC.


PLOS Genetics | 2010

Fragile X Mental Retardation Protein Regulates Proliferation and Differentiation of Adult Neural Stem/Progenitor Cells

Yuping Luo; Ge Shan; Weixiang Guo; Richard D. Smrt; Eric B. Johnson; Xuekun Li; Rebecca L. Pfeiffer; Keith E. Szulwach; Ranhui Duan; Basam Z. Barkho; Wendi Li; Chang-Mei Liu; Peng-Peng Jin; Xinyu Zhao

Fragile X syndrome (FXS), the most common form of inherited mental retardation, is caused by the loss of functional fragile X mental retardation protein (FMRP). FMRP is an RNA–binding protein that can regulate the translation of specific mRNAs. Adult neurogenesis, a process considered important for neuroplasticity and memory, is regulated at multiple molecular levels. In this study, we investigated whether Fmrp deficiency affects adult neurogenesis. We show that in a mouse model of fragile X syndrome, adult neurogenesis is indeed altered. The loss of Fmrp increases the proliferation and alters the fate specification of adult neural progenitor/stem cells (aNPCs). We demonstrate that Fmrp regulates the protein expression of several components critical for aNPC function, including CDK4 and GSK3β. Dysregulation of GSK3β led to reduced Wnt signaling pathway activity, which altered the expression of neurogenin1 and the fate specification of aNPCs. These data unveil a novel regulatory role for Fmrp and translational regulation in adult neurogenesis.


Nature Biotechnology | 2008

A small molecule enhances RNA interference and promotes microRNA processing

Ge Shan; Yujing Li; Junliang Zhang; Wendi Li; Keith E. Szulwach; Ranhui Duan; Mohammad Ali Faghihi; Ahmad M. Khalil; Lianghua Lu; Zain Paroo; Anthony W.S. Chan; Zhangjie Shi; Qinghua Liu; Claes Wahlestedt; Chuan He; Peng Jin

Small interfering RNAs (siRNAs) and microRNAs (miRNAs) are sequence-specific post-transcriptional regulators of gene expression. Although major components of the RNA interference (RNAi) pathway have been identified, regulatory mechanisms for this pathway remain largely unknown. Here we demonstrate that the RNAi pathway can be modulated intracellularly by small molecules. We have developed a cell-based assay to monitor the activity of the RNAi pathway and find that the small-molecule enoxacin (Penetrex) enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. We show that this RNAi-enhancing activity depends on the trans-activation-responsive region RNA-binding protein. Our results provide a proof-of-principle demonstration that small molecules can be used to modulate the activity of the RNAi pathway. RNAi enhancers may be useful in the development of research tools and therapeutics.


Nature Protocols | 2012

Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine

Miao Yu; Gary C. Hon; Keith E. Szulwach; Chun-Xiao Song; Peng Jin; Bing Ren; Chuan He

A complete understanding of the potential function of 5-hydroxymethylcytosine (5-hmC), a DNA cytosine modification in mammalian cells, requires an accurate single-base resolution sequencing method. Here we describe a modified bisulfite-sequencing method, Tet-assisted bisulfite sequencing (TAB-seq), which can identify 5-hmC at single-base resolution, as well as determine its abundance at each modification site. This protocol involves β-glucosyltransferase (β-GT)-mediated protection of 5-hmC (glucosylation) and recombinant mouse Tet1(mTet1)-mediated oxidation of 5-methylcytosine (5-mC) to 5-carboxylcytosine (5-caC). After the subsequent bisulfite treatment and PCR amplification, both cytosine and 5-caC (derived from 5-mC) are converted to thymine (T), whereas 5-hmC reads as C. The treated genomic DNA is suitable for both whole-genome and locus-specific sequencing. The entire procedure (which does not include data analysis) can be completed in 14 d for whole-genome sequencing or 7 d for locus-specific sequencing.

Collaboration


Dive into the Keith E. Szulwach's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Chuan He

Howard Hughes Medical Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hao Wu

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Xinyu Zhao

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Qing Dai

University of Chicago

View shared research outputs
Top Co-Authors

Avatar

Bing Ren

Ludwig Institute for Cancer Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge